Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
209 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06747585 | A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors | recruiting | Phase 1 / Phase 2 | 170 | Alentis Therapeutics AGINDUSTRY | 8 | Jun 29, 2026 | clinicaltrials |
| NCT00196742 | Fabry Disease Registry & Pregnancy Sub-registry | recruiting | — | 9,000 | Genzyme, a Sanofi CompanyINDUSTRY | 44 | Jun 23, 2026 | clinicaltrials |
| NCT07215585 |
| AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL(SOUNDTRACK-D2) |
| recruiting |
| Phase 3 |
| 420 |
| AstraZenecaINDUSTRY |
| 11 |
| Jun 18, 2026 |
| clinicaltrials |
| NCT05475925 | A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas | recruiting | Phase 1 / Phase 2 | 200 | Dren BioINDUSTRY | 9 | Jun 17, 2026 | clinicaltrials |
| NCT05208047 | (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors | recruiting | Phase 3 | 482 | Cogent Biosciences, Inc.INDUSTRY | 22 | Jun 16, 2026 | clinicaltrials |
| NCT05762731 | Screening for Lung Cancer in Subjects With Family History of Lung Cancer | recruiting | — | 1,520 | The University of Hong KongOTHER | 1 | Jun 9, 2026 | clinicaltrials |
| NCT06815575 | A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours. | recruiting | Phase 1 | 53 | Racura Oncology LtdINDUSTRY | 3 | Jun 2, 2026 | clinicaltrials |
| NCT07369596 | Impact of Chemotherapy Dose Reductions on Survival Outcomes Among Older NSCLC Patients Without Actionable Mutations | recruiting | — | 150 | University of MalayaOTHER | 2 | Jun 2, 2026 | clinicaltrials |
| NCT03093116 | A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements(TRIDENT-1) | recruiting | Phase 1 / Phase 2 | 500 | Turning Point Therapeutics, Inc.INDUSTRY | 19 | May 27, 2026 | clinicaltrials |
| NCT06551142 | A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)(PanTumor-101) | recruiting | Phase 1 | 845 | GlaxoSmithKlineINDUSTRY | 13 | May 22, 2026 | clinicaltrials |
| NCT07484932 | TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer | recruiting | N/A | 400 | The University of Hong KongOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT06434480 | SBRT in HCC With Oligoprogression on First-line Immunotherapy | recruiting | N/A | 30 | Chinese University of Hong KongOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT06417814 | A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(TROPION-Lung15) | recruiting | Phase 3 | 744 | AstraZenecaINDUSTRY | 27 | May 14, 2026 | clinicaltrials |
| NCT07572396 | Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities | recruiting | Phase 2 | 45 | Amplexd Therapeutics, Inc.INDUSTRY | 1 | May 14, 2026 | clinicaltrials |
| NCT06023862 | A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)(DOVE) | recruiting | Phase 2 | 198 | Yonsei UniversityOTHER | 7 | May 6, 2026 | clinicaltrials |
| NCT06160323 | Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer | recruiting | N/A | 94 | Chinese University of Hong KongOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT06367270 | The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies(PIPAC) | recruiting | Phase 2 | 60 | The University of Hong KongOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07551440 | Identification of Therapeutic Targets in Metastatic Gastric Cancer | recruiting | — | 100 | Chinese University of Hong KongOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT04852887 | De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)(DEBRA) | recruiting | Phase 3 | 1,670 | NRG OncologyOTHER | 4 | Apr 23, 2026 | clinicaltrials |
| NCT06957015 | A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size(EndoAIM) | recruiting | N/A | 278 | Chinese University of Hong KongOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT05580562 | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)(ACTION) | recruiting | Phase 3 | 510 | Jazz PharmaceuticalsINDUSTRY | 18 | Apr 16, 2026 | clinicaltrials |
| NCT07293468 | Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)(BIIRTH) | recruiting | Phase 2 / Phase 3 | 106 | Tuen Mun HospitalOTHER_GOV | 1 | Apr 9, 2026 | clinicaltrials |
| NCT07517432 | The UGIRA International Registry for RAMIG for Gastric Cancer | recruiting | — | 200 | Chinese University of Hong KongOTHER | 1 | Apr 8, 2026 | clinicaltrials |
| NCT06584110 | Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family Caregivers(BUDPA) | recruiting | N/A | 236 | The University of Hong KongOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT05296109 | Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation | recruiting | N/A | 50 | Chinese University of Hong KongOTHER | 1 | Apr 3, 2026 | clinicaltrials |
| NCT06351631 | A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) | recruiting | Phase 3 | 400 | Merck Sharp & Dohme LLCINDUSTRY | 6 | Apr 2, 2026 | clinicaltrials |
| NCT07455955 | Personalized Antiemetic Regimen According to Patients' Pharmacogenetic Profile | recruiting | Phase 2 | 200 | Chinese University of Hong KongOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT06692335 | HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids | recruiting | N/A | 112 | Chinese University of Hong KongOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT07487064 | Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study(TARGET) | recruiting | N/A | 25 | Galvanize Therapeutics, Inc.INDUSTRY | 1 | Mar 23, 2026 | clinicaltrials |
| NCT03218345 | EUS-guided RFA for Pancreatic Neoplasms | recruiting | N/A | 30 | Chinese University of Hong KongOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT03221335 | EUS-guided RFA for Solid Abdominal Neoplasms | recruiting | N/A | 30 | Chinese University of Hong KongOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06669104 | Thoracic Surgery by the Medtronic Hugo™ Robotic System | recruiting | — | 50 | Chinese University of Hong KongOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT07159659 | Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection | recruiting | N/A | 210 | Chinese University of Hong KongOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT05629845 | Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients(EUS-SPV) | recruiting | N/A | 84 | Chinese University of Hong KongOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT06077591 | Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors(PDO) | recruiting | N/A | 40 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT06295497 | Lung Cancer Screening in HIgh Risk nonsmokErs by Artificial inteLligence Device | recruiting | N/A | 3,000 | Chinese University of Hong KongOTHER | 1 | Mar 18, 2026 | clinicaltrials |
| NCT07130682 | Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial(PT2) | recruiting | N/A | 35 | Hong Kong Sanatorium & HospitalINDUSTRY | 1 | Mar 16, 2026 | clinicaltrials |
| NCT04706481 | Archival of Human Biological Samples in CU-Med Biobank | recruiting | — | 10,000 | Chinese University of Hong KongOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT07052110 | DST in Reducing Depressive Symptoms, Enhancing Self-esteem, and Promoting Quality of Life Among CCSs | recruiting | N/A | 248 | The Hong Kong Polytechnic UniversityOTHER | 1 | Mar 12, 2026 | clinicaltrials |
| NCT06636188 | An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy(Digi-Coach) | recruiting | N/A | 138 | The University of Hong KongOTHER | 1 | Mar 9, 2026 | clinicaltrials |
| NCT06823375 | SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis | recruiting | Phase 2 | 40 | Chinese University of Hong KongOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06885879 | Impact of Radiotherapy on ctDNA in Patients With Hepatocellular Carcinoma | recruiting | — | 15 | Chinese University of Hong KongOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06769061 | The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients(AcuCIN) | recruiting | N/A | 75 | Karen Kar Loen CHANOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT06303622 | Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial | recruiting | N/A | 1,250 | Chinese University of Hong KongOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07411118 | RCT of EFTR Versus STER for GIST Treatment | recruiting | N/A | 136 | Chinese University of Hong KongOTHER | 4 | Feb 13, 2026 | clinicaltrials |
| NCT07379476 | Local Ablative Therapy to Oligoresidual Metastasis in EGFR Mutated Non-small Cell Lung Cancer | recruiting | Phase 2 | 64 | Chinese University of Hong KongOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT07107490 | A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER | recruiting | Phase 1 | 122 | Chugai PharmaceuticalINDUSTRY | 3 | Feb 6, 2026 | clinicaltrials |
| NCT06043609 | Outcome Evaluation After Fertility Preservation | recruiting | — | 100 | Chinese University of Hong KongOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT06505057 | Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients (HKCH) | recruiting | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT05830929 | Ovarian Tissue Cryopreservation and Subsequent Auto-Transplantation for Female Cancer Patients | recruiting | N/A | 100 | Chinese University of Hong KongOTHER | 1 | Jan 7, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials